Emcure Pharmaceuticals Receives USFDA Form 483 With Seven Observations
Emcure Pharmaceuticals received a USFDA Form 483 with seven observations following a cGMP inspection at its Sanand manufacturing facility in Gujarat.
Emcure Pharmaceuticals received a USFDA Form 483 with seven observations following a cGMP inspection at its Sanand manufacturing facility in Gujarat.
